Invitrogen™ Human Caspase-1 ELISA Kit

Ref.: BL-RE-106386Manufacturer ref.: EH70RB 96 tests
€732.00 excl. VAT

Human Caspase-1 quantitates human Caspase-1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Caspase-1.

Accession number
CASP1 ; CASP-1 ; CASP1 nirs variante 1 ; caspase 1 ; caspase 1, cystéine peptidase liée à l’apoptose (interleukine 1, bêta, convertase) ; caspase1 ; caspase-1 ; sous-unité caspase-1 p10 ; sous-unité caspase-1 p20 ; ICE ; enzyme de conversion bêta IL-1 ; enzyme de conversion IL-1 B ; IL1BC ; IL-1 BC ; IL1BCE ; IL1B-convertase ; Interleukine 1, enzyme de conversion bêta ; interleukine 1, bêta, convertase ; interleukine 1-B, enzyme de conversion ; Interleukine 1, enzyme de conversion bêta ; interleukine 1, bêta-convertase ; interleukine 1, enzyme de conversion bêta ; p45
Dose range
0.43 to 100 pg/ml
Sensitivity of the dosage
0.43 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human Caspase-1 quantitates human Caspase-1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Caspase-1.

Human Caspase-1 quantitates human Caspase-1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Caspase-1.

Caspases are a family of cysteine proteases that can be divided into subfamilies of apoptotic and inflammatory caspase. Unlike apoptotic caspases, members of the inflammatory subfamily are generally not involved in cell death but are associated with the immune response to microbial pathogens. Members of this subfamily include caspases-1, -4, -5 and -12 and may activate pro-inflammatory cytokines such as l的IL-1-b and l的IL-18. Caspase-1 was first identified as a conversion enzyme of l-l-l-l-b; subsequent experiments showed that it was homologous in mammals to the cell death gene of C. elegans cd-3 whose overexpression may induce apoptosis in fibroblasts.

Sensitivity

Sensitivity of dosage: 0.43 ng/ml.

Measurement range

Dose range: 0.43 to 100 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: Caspase 1.

Samples

Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)16895441
Specifications
Accession numberCASP1; CASP-1; CASP1 nirs variant 1 ; caspase 1 ; caspase 1, caspase 1 ; caspase 1 p10 ; caspase 1 p20 ; caspase 1 p20 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p20 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p20 ; caspase 1 p20 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p20 ; caspase 1 p20 ; caspase 1 p20 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p20 ; caspase 1 p20 ; caspase 1 p20 ; caspase 1 p20 ; caspase 1 p20 ; caspase 1 p20 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p10 ; caspase 1 p10 ICE; beta conversion enzyme IL-1; conversion enzyme IL-1 B; IL1BC; IL-1 BC
Dose range0.43 to 100 pg/ml
Sensitivity of the dosage0.43 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)P29466
Gene symbol(s)CASP1
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity96 tests
Regulatory statusUse exclusively for research
TargetCaspase 1
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 µl; plasma, 50 µl; supernatant, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH70RB
Country of originPays-Bas
HS customs code3822 19 00 00
A question or a specific configuration?
Contact us for a quote.